LONG-TERM TREATMENT WITH ONABOTULINUMTOXINA: EFFICACY AND SAFETY PROFILE IN PATIENTS WITH URINARY INCONTINENCE DUE TO NEUROGENIC DETRUSOR OVERACTIVITY

被引：0
|
作者：
Del Popolo, Giulio [1 ]
Karsenty, Gilles [2 ]
Schulte-baukloh, Heinrich [3 ]
Dmochowski, Roger [4 ]
Ethans, Karen [5 ]
Jenkins, Brenda [6 ]
Guard, Steven [7 ]
Lee, Ho-jin [8 ]
Kennelly, Michael [9 ]
机构：
[1] Aou Careggi, Sod Neurourol, Florence, Italy
[2] Univ Aix Marseille 2, F-13284 Marseille 07, France
[3] St Hedwig Krankenhaus, Berlin, Germany
[4] Vanderbilt Univ, Nashville, TN 37235 USA
[5] Univ Manitoba, Winnipeg, MB, Canada
[6] Allergan Pharmaceut Inc, Irvine, CA 92715 USA
[7] Allergan Ltd, Marlow, Bucks, England
[8] Allergan Pharmaceut Inc, Bridgewater, MA USA
[9] Carolinas Rehabil, Urol, Charlotte, NC USA
来源：
NEUROUROLOGY AND URODYNAMICS | 2014年 / 33卷
关键词：
INJURY;
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S37 / S37
页数：1
相关论文
共 50 条
  • [1] LONG-TERM EFFICACY AND SAFETY OF ONABOTULINUMTOXINA IN PATIENTS WITH URINARY INCONTINENCE DUE TO NEUROGENIC DETRUSOR OVERACTIVITY
    Kennelly, Michael
    Dmochowski, Roger
    Ethans, Karen
    Karsenty, Gilles
    Lemack, Gary
    Schulte-Baukloh, Heinrich
    Jenkins, Brenda
    Thompson, Catherine
    Li, Daniel
    Haag-Molkenteller, Cornelia
    JOURNAL OF UROLOGY, 2012, 187 (04): : E668 - E669
  • [2] Long-term Efficacy and Safety of OnabotulinumtoxinA in Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity: An Interim Analysis
    Kennelly, Michael
    Dmochowski, Roger
    Ethans, Karen
    Karsenty, Gilles
    Schulte-Baukloh, Heiner
    Jenkins, Brenda
    Thompson, Catherine
    Li, Daniel
    Haag-Molkenteller, Cornelia
    UROLOGY, 2013, 81 (03) : 491 - 497
  • [3] EFFICACY AND SAFETY OF ONABOTULINUMTOXINA IN PATIENTS WITH URINARY INCONTINENCE DUE TO NEUROGENIC DETRUSOR OVERACTIVITY
    Cruz, F.
    Herschorn, S.
    Heesakkers, J.
    Aliotta, P.
    Thompson, C.
    Lam, W.
    Daniell, G.
    Haag-Molkenteller, C.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 190 - 190
  • [4] Efficacy and safety of onabotulinumtoxinA in multiple sclerosis patients with urinary incontinence due to neurogenic detrusor overactivity
    Cruz, F.
    Herschorn, S.
    Heesakkers, J.
    Aliotta, P.
    Thompson, C.
    Lam, W.
    Daniell, G.
    Haag-Molkenteller, C.
    JOURNAL OF NEUROLOGY, 2011, 258 : 22 - 22
  • [5] SUSTAINED IMPROVEMENTS IN URINARY INCONTINENCE AND QUALITY OF LIFE OVER LONG-TERM TREATMENT WITH ONABOTULINUMTOXINA IN PATIENTS WITH URINARY INCONTINENCE DUE TO NEUROGENIC DETRUSOR OVERACTIVITY
    Kennelly, Michael
    Dmochowski, Roger
    Schulte-Baukloh, Heinrich
    Ethans, Karen
    Jenkins, Brenda
    Guard, Steven
    Lee, Ho-Jin
    Karsenty, Gilles
    JOURNAL OF UROLOGY, 2014, 191 (04): : E942 - E942
  • [6] PHASE 3 EFFICACY AND SAFETY STUDY OF ONABOTULINUMTOXINA IN PATIENTS WITH URINARY INCONTINENCE DUE TO NEUROGENIC DETRUSOR OVERACTIVITY
    Ginsberg, David
    Gousse, Angelo
    Keppenne, Veronique
    Sievert, Karl-Dietrich
    Thompson, Catherine
    Lam, Wayne
    Jenkins, Brenda
    Molkenteller, Cornelia Haag
    JOURNAL OF UROLOGY, 2011, 185 (04): : E607 - E607
  • [7] Phase 3 efficacy and safety study of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity
    Chapple, C. R.
    Fowler, C.
    Conn, G.
    Ginsberg, D.
    Lam, W.
    Thompson, C.
    BJU INTERNATIONAL, 2011, 108 : 20 - 20
  • [8] Phase 3 efficacy and safety study of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity
    Dmochowski, R.
    Ginsberg, D.
    Ethans, K.
    Brin, M.
    Lam, W.
    Haag-Molkenteller, C.
    TOXICON, 2013, 68 : 109 - 110
  • [9] A DOSE-EXPLORATION STUDY OF THE EFFICACY AND SAFETY OF ONABOTULINUMTOXINA IN PATIENTS WITH URINARY INCONTINENCE DUE TO NEUROGENIC DETRUSOR OVERACTIVITY
    Apostolidis, A.
    Mourad, S.
    Thompson, C.
    Yan, X.
    Haag-Molkenteller, C.
    NEUROUROLOGY AND URODYNAMICS, 2011, 30 (06) : 926 - 927
  • [10] LONG-TERM, SUSTAINED SAFETY AND EFFICACY OF REPEAT ONABOTULINUMTOXINA TREATMENT IN MULTIPLE SCLEROSIS PATIENTS WITH NEUROGENIC DETRUSOR OVERACTIVITY
    Del Popolo, Giulio
    Panicker, Jalesh
    Aliotta, Philip
    Joshi, Manher
    Jenckins, Brenda
    Zheng, Yan
    Kohan, Alfred
    NEUROUROLOGY AND URODYNAMICS, 2015, 34 : S3 - S4
12345